Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $66.83 and last traded at $66.40, with a volume of 4625 shares changing hands. The stock had previously closed at $65.94.
Novozymes A/S Price Performance
The stock has a market capitalization of $31.10 billion, a PE ratio of 41.73, a price-to-earnings-growth ratio of 3.55 and a beta of 0.89. The business’s 50-day moving average price is $62.29 and its 200 day moving average price is $59.36. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Recommended Stories
- Five stocks we like better than Novozymes A/S
- Most Volatile Stocks, What Investors Need to Know
- Advance Auto Parts Eyes Long-Term Growth Despite Q2 Hurdles
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Toll Brothers Stock Up on Q3 Beat: Luxury Homes Drive Growth
- Industrial Products Stocks Investing
- 4 No-Brainer Stocks to Hold This Fall for Steady Gains
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.